Skip to main content

Advertisement

SpringerLink
Log in

Reply to ‘Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels’ by Widmer et al.

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Widmer N, Rumpold H, Untergasser G, Fayet A, Buclin T, Decosterd LA . Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels. Leukemia (in press).

  2. Dai H, Marbach P, Lemaire M, Hayes M, Elmquist WF . Distribution of STI-571 to the brain is limited by P-glycoprotein-mediated efflux. J Pharmacol Exp Ther 2003; 304: 1085–1092.

    Article  CAS  PubMed  Google Scholar 

  3. Hamada A, Miyano H, Watanabe H, Saito H . Interaction of imatinib mesilate with human P-glycoprotein. J Pharmacol Exp Ther 2003; 307: 824–828.

    Article  CAS  PubMed  Google Scholar 

  4. Zong Y, Zhou S, Sorrentino BP . Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia. Leukemia 2005; 19: 1590–1596.

    Article  CAS  PubMed  Google Scholar 

  5. Gardner ER, Burger H, van Schaik RH, van Oosterom AT, de Bruijn EA, Guetens G et al. Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib. Clin Pharmacol Ther 2006; 80: 192–201.

    Article  CAS  PubMed  Google Scholar 

  6. Theou N, Gil S, Devocelle A, Julie C, Lavergne-Slove A, Beauchet A et al. Multidrug resistance proteins in gastrointestinal stromal tumors: site-dependent expression and initial response to imatinib. Clin Cancer Res 2005; 11: 7593–7598.

    Article  CAS  PubMed  Google Scholar 

  7. Zong Y, Zhou S, Sorrentino BP . Reply to Rumpold et al. Leukemia 2006; 20: 144–145.

    Article  CAS  PubMed  Google Scholar 

  8. Houghton PJ, Germain GS, Harwood FC, Schuetz JD, Stewart CF, Buchdunger E et al. Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro. Cancer Res 2004; 64: 2333–2337.

    Article  CAS  PubMed  Google Scholar 

  9. Jordanides NE, Jorgensen HG, Holyoake TL, Mountford JC . Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate. Blood 2006; 108: 1370–1373.

    Article  CAS  Google Scholar 

  10. Nakanishi T, Shiozawa K, Hassel BA, Ross DD . Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression. Blood 2006; 108: 678–684.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Experimental Hematology, Department of Hematology–Oncology, St Jude Children's Research Hospital, Memphis, TN, USA

    Y Zong, S Zhou & B P Sorrentino

  2. The Interdisciplinary Program, College of Graduate Health Sciences, the University of Tennessee Health Science Center, Memphis, TN, USA

    Y Zong & B P Sorrentino

Authors
  1. Y Zong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B P Sorrentino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B P Sorrentino.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zong, Y., Zhou, S. & Sorrentino, B. Reply to ‘Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels’ by Widmer et al.. Leukemia 21, 1562–1563 (2007). https://doi.org/10.1038/sj.leu.2404672

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404672

  • Springer Nature Limited

This article is cited by

Search

Navigation